- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01744847
DGT Versus TPS in Patients With Initial PD Cannulation by Chance; Prospective Multi-center Study
DGT Versus TPS in Patients With Initial PD Cannulation by Chance; Prospective Randomized Multi-center Study
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
This was a prospective, randomized study conducted in three tertiary referral hospital in Korea. Three endoscopists performed the ERCP who had ERCP experience more than ten years From October 2010 to August 2012, ERCPs were performed on patients with pancreatobiliary diseases at Soonchunhyang University Seoul Hospital, Hanyang University Guri Hospital and Kosin University Gospel Hospital. Bile duct cannulation was attempted for various reasons (removal of bile duct stones, biliary stenting, cytology of bile, biopsy of the bile duct, etc.).
Patients who satisfied the following inclusion criteria were enrolled in this study: (1) initially pancreatic duct cannulation by chance, (2) successful insertion of the guidewire into the pancreatic duct to at least half of the presumed total length of the pancreatic duct,, and (3) age 20 years or older. Exclusion criteria were: (1) refusal the ERCP, (2) previous endoscopic sphincterotomy or endoscopic papillary balloon dilatation, (3) acute pancreatitis at the time of the procedure, (4) pregnancy and (5) anatomical change due to past surgery; total gastrectomy, Billroth II operation, Whipples's operation etc. Patients who satisfied the inclusion criteria were randomly assigned to either the double-guidewire technique (DGT) group or the transpancreatic precut sphincterotomy (TPS) group; A randomization list for group allocation was generated by using computer-based pseudo-random number generators. We compared both techniques , for a maximum of ten extra attempts which are CBD cannulation by each methods. We obtained the written informed consent from all enrolled patients.
Study Type
Enrollment (Actual)
Phase
- Phase 4
Contacts and Locations
Study Locations
-
-
Yongsan-gu
-
Seoul, Yongsan-gu, Korea, Republic of, 140-743
- Institute for Digestive Research, Digestive Disease Center, Department of Internal Medicine, Soonchunhyang University College of Medicine, Soonchunhyang University Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- ERCP patient, over 20 years old, pancreatic duct cannulation patients by chance
Exclusion Criteria:
- refuse the ERCP, post procedure state(EST, subtotal gastrectomy, Whipples' Op except gastroduodenostomy), use another method, under 20 years old.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: DGT, Tracer Metro® Direct™ Wire Guide
Double guide wire technique was performed by Tracer Hybrid® Wire Guides and Tracer Metro® Direct™ Wire Guide
|
one guide wire insert to the pancreatic duct and other guide wire insert to the Common bilde duct for cannulation
Other Names:
|
|
Active Comparator: TPS, Tracer Hybrid® Wire Guides
trans pancreatic sphincterotomy was performed by Tracer Hybrid® Wire Guides
|
one guide wire insert to the pancreatic duct and other guide wire insert to the Common bilde duct for cannulation
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
success rate between DGT and TPS
Time Frame: up to 22months
|
from October 2010 to August 2012
|
up to 22months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
median cannulation time between DGT and TPS
Time Frame: during precedure time
|
median time for precedure
|
during precedure time
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
pancreatitis rate between DGT and TPS
Time Frame: upto 1 week
|
We observation for the comlication upto 1 week after ERCP
|
upto 1 week
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- MD-2012-010
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cholecystitis
-
Konya Meram State HospitalCompleted
-
Hospital General de Chihuahua - Dr. Salvador Zubirán...CompletedAcute Cholecystitis | Acute Cholecystitis With ObstructionMexico
-
The University of Texas Health Science Center at...CompletedAcute Cholecystitis | Chronic CholecystitisUnited States
-
Azienda Ospedaliero, Universitaria PisanaCompletedAcute CholecystitisItaly
-
University Hospital, GhentCompletedUncomplicated Acute CholecystitisBelgium, Qatar
-
Istituto Clinico Humanitas Mater DominiRecruiting
-
Centre Hospitalier Universitaire de NīmesCompleted
-
Taipei Medical University Shuang Ho HospitalCompletedAcute CholecystitisTaiwan
-
Hvidovre University HospitalZealand University Hospital; Hillerod Hospital, DenmarkWithdrawn
-
Hospital Italiano de Buenos AiresCompletedAcute CholecystitisArgentina